Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.
Neuro Therapia has raised $12.3M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
Neuro Therapia's investors include Cleveland Clinic, Alzheimer's Drug Discovery Foundation, Alzheimer's Association, Dolby Family Ventures, CRUINT.
Neuro Therapia is headquartered in Ohio, United States.
Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.
Neuro Therapia is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuro Therapia — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/neuro-therapia. Accessed September 14, 2026.
VCBacked. (2024). Neuro Therapia — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/neuro-therapia
{{cite web |title=Neuro Therapia — Funding & Investors |url=https://www.vcbacked.co/company/neuro-therapia |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated